Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)

NCT01456260 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers

NCT00762359 ·Status: TERMINATED ·Phase: PHASE3

Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]

NCT02170207 ·Status: COMPLETED

Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

NCT01452763 ·Status: COMPLETED ·Phase: PHASE3

Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin: Long-term Use"

NCT03214094 ·Status: COMPLETED

Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis

NCT01182597 ·Status: UNKNOWN ·Phase: PHASE3

Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin

NCT01456247 ·Status: COMPLETED ·Phase: PHASE3

A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy

NCT01568385 ·Status: COMPLETED ·Phase: PHASE3

Nexium Capsules LDA Specific Clinical Experience Investigation

NCT01729182 ·Status: COMPLETED

Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs

NCT04840550 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer

NCT01452711 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers

NCT06439563 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer

NCT01452724 ·Status: COMPLETED ·Phase: PHASE3

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection

NCT03050359 ·Status: COMPLETED ·Phase: PHASE3

Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

NCT00595517 ·Status: COMPLETED ·Phase: PHASE3

Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients

NCT02456012 ·Status: COMPLETED ·Phase: PHASE4

Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection

NCT03050307 ·Status: COMPLETED ·Phase: PHASE3

Ulcer Prevention II

NCT00629928 ·Status: COMPLETED ·Phase: PHASE3

Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation

NCT01562600 ·Status: COMPLETED

Prevention of Gastric Ulcers

NCT00629512 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Gastric Ulcer

NCT02761512 ·Status: COMPLETED ·Phase: PHASE3

A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy

NCT01568398 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer

NCT01138969 ·Status: COMPLETED ·Phase: PHASE2

Prevention of Recurrent Ulcer Bleeding in Patients With Idiopathic Gastroduodenal Ulcer

NCT03675672 ·Status: RECRUITING ·Phase: PHASE4

Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation

NCT01051388 ·Status: COMPLETED ·Phase: PHASE3